METHYL 4-AMINO-3-BROMO-5-NITROPHENYLACETATE, 95.0%, 1g

(3-(3-Fluorophenyl)-1,2,4-oxadiazol-5-yl)methanamine, 98%, 250mg

3-Phenylpyridin-2-ol, 95.0%, 5g

3-Acetylbenzo[b]furan, 1g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 10 ml, 3500–5000 dalton(s), 12 Piece(s)

2,2'':7'',2''''-Ter-9,9'-spirobi[9H-fluorene]>98.0%(HPLC)200mg

N-[(3-Fluorophenyl)methyl]piperazine-1-carboxamide hydrochloride, 1g

Lovastatin, >95%, 100g

2,2-dimethyl-4-oxo-4-(4-thiomethylphenyl)butryic acid, 97.0%, 1g

Butyl Benzenesulfonate>98.0%(GC)25mL

2,6-Dimethylbenzaldehyde>97.0%(GC)25g

4-(1 H -Benzoimidazol-2-yl)-phenylamine, 95.0%, 2.5g

3-(Diethylamino)propanamide, 97%, 250mg